Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.
Garvan Institute of Medical Research, The Kinghorn Cancer Centre, Faculty of Medicine, St Vincent's Clinical School, University of NSW, Darlinghurst, NSW 2010, Australia.
Cancer Cell. 2015 Aug 10;28(2):155-69. doi: 10.1016/j.ccell.2015.07.003.
Metastasis is the major cause of breast cancer mortality. Phosphoinositide 3-kinase (PI3K) generated PtdIns(3,4,5)P3 activates AKT, which promotes breast cancer cell proliferation and regulates migration. To date, none of the inositol polyphosphate 5-phosphatases that inhibit PI3K/AKT signaling have been reported as tumor suppressors in breast cancer. Here, we show depletion of the inositol polyphosphate 5-phosphatase PIPP (INPP5J) increases breast cancer cell transformation, but reduces cell migration and invasion. Pipp ablation accelerates oncogene-driven breast cancer tumor growth in vivo, but paradoxically reduces metastasis by regulating AKT1-dependent tumor cell migration. PIPP mRNA expression is reduced in human ER-negative breast cancers associated with reduced long-term outcome. Collectively, our findings identify PIPP as a suppressor of oncogenic PI3K/AKT signaling in breast cancer.
转移是乳腺癌死亡的主要原因。磷酸肌醇 3-激酶 (PI3K) 产生的 PtdIns(3,4,5)P3 激活 AKT,促进乳腺癌细胞增殖并调节迁移。迄今为止,尚无报道称抑制 PI3K/AKT 信号的肌醇多磷酸 5-磷酸酶作为乳腺癌的肿瘤抑制因子。在这里,我们表明肌醇多磷酸 5-磷酸酶 PIPP(INPP5J)的耗尽会增加乳腺癌细胞的转化,但会减少细胞迁移和侵袭。Pipp 缺失加速了致癌基因驱动的乳腺癌在体内的肿瘤生长,但通过调节 AKT1 依赖性肿瘤细胞迁移,出人意料地减少了转移。PIKP mRNA 的表达在与长期预后不良相关的人 ER 阴性乳腺癌中降低。总的来说,我们的研究结果表明 PIPP 是乳腺癌致癌性 PI3K/AKT 信号的抑制因子。